June 30, 2017 Hamden, Connecticut – Vanessa Research, Inc. (VRI), an emerging healthcare and biotech company, announced today that the European Patent Office (EPO) has issued a patent for the formulation of an oral anti-diarrheal treatment for babies and young children with Microvillus Inclusion Disease (MVID). The U.S. and world patents are pending. The formula,...